These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 24814552)

  • 1. Protective humoral immune response induced by an inactivated porcine reproductive and respiratory syndrome virus expressing the hypo-glycosylated glycoprotein 5.
    Lee JA; Kwon B; Osorio FA; Pattnaik AK; Lee NH; Lee SW; Park SY; Song CS; Choi IS; Lee JB
    Vaccine; 2014 Jun; 32(29):3617-22. PubMed ID: 24814552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Porcine GPX1 enhances GP5-based DNA vaccination against porcine reproductive and respiratory syndrome virus.
    Du L; Li B; Pang F; Yu Z; Xu X; Fan B; Tan Y; He K; Huang K
    Vet Immunol Immunopathol; 2017 Jan; 183():31-39. PubMed ID: 28063474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD40 ligand expressed in adenovirus can improve the immunogenicity of the GP3 and GP5 of porcine reproductive and respiratory syndrome virus in swine.
    Cao J; Wang X; Du Y; Li Y; Wang X; Jiang P
    Vaccine; 2010 Nov; 28(47):7514-22. PubMed ID: 20851084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a DNA vaccine candidate co-expressing GP3 and GP5 of porcine reproductive and respiratory syndrome virus (PRRSV) with interferon α/γ in immediate and long-lasting protection against HP-PRRSV challenge.
    Du Y; Qi J; Lu Y; Wu J; Yoo D; Liu X; Zhang X; Li J; Sun W; Cong X; Shi J; Wang J
    Virus Genes; 2012 Dec; 45(3):474-87. PubMed ID: 22843314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HSP70 fused with GP3 and GP5 of porcine reproductive and respiratory syndrome virus enhanced the immune responses and protective efficacy against virulent PRRSV challenge in pigs.
    Li J; Jiang P; Li Y; Wang X; Cao J; Wang X; Zeshan B
    Vaccine; 2009 Feb; 27(6):825-32. PubMed ID: 19070639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenic and protective properties of GP5 and M structural proteins of porcine reproductive and respiratory syndrome virus expressed from replicating but nondisseminating adenovectors.
    Roques E; Girard A; St-Louis MC; Massie B; Gagnon CA; Lessard M; Archambault D
    Vet Res; 2013 Mar; 44(1):17. PubMed ID: 23497101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced humoral and cellular immune responses to PRRS virus GP5 glycoprotein by DNA prime-adenovirus boost vaccination in mice.
    Yu M; Qiu Y; Chen J; Jiang W
    Virus Genes; 2016 Apr; 52(2):228-34. PubMed ID: 26837895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a porcine reproductive and respiratory syndrome virus-like-particle-based vaccine and evaluation of its immunogenicity in pigs.
    Binjawadagi B; Lakshmanappa YS; Longchao Z; Dhakal S; Hiremath J; Ouyang K; Shyu DL; Arcos J; Pengcheng S; Gilbertie A; Zuckermann F; Torrelles JB; Jackwood D; Fang Y; Renukaradhya GJ
    Arch Virol; 2016 Jun; 161(6):1579-89. PubMed ID: 27008569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of recombinant vaccinia virus vaccines co-expressing GP3/GP5 of European PRRSV and Cap protein of PCV2 in pigs.
    Han J; Ma H; Cao L; Jing J; Xiao P; Sun W; Xie C; Wen S; Li Y; Tian M; Lu H; Jin N
    Appl Microbiol Biotechnol; 2018 Feb; 102(3):1145-1154. PubMed ID: 29189898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the efficacy of autogenous inactivated Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) vaccines with that of commercial vaccines against homologous and heterologous challenges.
    Geldhof MF; Vanhee M; Van Breedam W; Van Doorsselaere J; Karniychuk UU; Nauwynck HJ
    BMC Vet Res; 2012 Oct; 8():182. PubMed ID: 23031319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective immunity induced by a recombinant pseudorabies virus expressing the GP5 of porcine reproductive and respiratory syndrome virus in piglets.
    Qiu HJ; Tian ZJ; Tong GZ; Zhou YJ; Ni JQ; Luo YZ; Cai XH
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):309-19. PubMed ID: 15963827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The assessment of efficacy of porcine reproductive respiratory syndrome virus inactivated vaccine based on the viral quantity and inactivation methods.
    Kim H; Kim HK; Jung JH; Choi YJ; Kim J; Um CG; Hyun SB; Shin S; Lee B; Jang G; Kang BK; Moon HJ; Song DS
    Virol J; 2011 Jun; 8():323. PubMed ID: 21703032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody response and maternal immunity upon boosting PRRSV-immune sows with experimental farm-specific and commercial PRRSV vaccines.
    Geldhof MF; Van Breedam W; De Jong E; Lopez Rodriguez A; Karniychuk UU; Vanhee M; Van Doorsselaere J; Maes D; Nauwynck HJ
    Vet Microbiol; 2013 Dec; 167(3-4):260-71. PubMed ID: 24041768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant adenovirus expressing GP5 and M fusion proteins of porcine reproductive and respiratory syndrome virus induce both humoral and cell-mediated immune responses in mice.
    Jiang W; Jiang P; Li Y; Tang J; Wang X; Ma S
    Vet Immunol Immunopathol; 2006 Sep; 113(1-2):169-80. PubMed ID: 16777236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of recombinant GP5 protein of porcine reproductive and respiratory syndrome virus expressed in tobacco plant.
    Chia MY; Hsiao SH; Chan HT; Do YY; Huang PL; Chang HW; Tsai YC; Lin CM; Pang VF; Jeng CR
    Vet Immunol Immunopathol; 2010 Jun; 135(3-4):234-42. PubMed ID: 20053461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of dynamics of immune responses and protective efficacy in piglets immunized with an inactivated porcine reproductive and respiratory syndrome vaccine candidate.
    Pandey MK; Rajukumar K; Senthilkumar D; Kombiah S; Singh F; Venkatesh G; Kumar M; Shrivas S; Shrivastava D; Singh VP; Sanyal A
    Vaccine; 2023 Oct; 41(42):6327-6338. PubMed ID: 37689543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-expressing GP5 and M proteins under different promoters in recombinant modified vaccinia virus ankara (rMVA)-based vaccine vector enhanced the humoral and cellular immune responses of porcine reproductive and respiratory syndrome virus (PRRSV).
    Zheng Q; Chen D; Li P; Bi Z; Cao R; Zhou B; Chen P
    Virus Genes; 2007 Dec; 35(3):585-95. PubMed ID: 17922181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of Taishan Pinus massoniana pollen polysaccharide on the immune response and protection elicited by a highly pathogenic porcine reproductive and respiratory syndrome virus glycoprotein 5 subunit in pigs.
    Peng J; Yuan Y; Du Y; Wu J; Li B; Li J; Yu J; Hu L; Shen S; Wang J; Zhu R
    Mol Cell Probes; 2016 Apr; 30(2):83-92. PubMed ID: 26828953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic Homologous Neutralizing Antibodies Are Inadequate for the Evaluation of Vaccine Protective Efficacy against Coinfection by High Virulent PEDV and PRRSV.
    Qiu M; Li S; Ye M; Li J; Sun Z; Li X; Xu Y; Xiao Y; Li C; Feng B; Lin H; Zheng W; Yu X; Tian K; Zhu J; Chen N
    Microbiol Spectr; 2022 Apr; 10(2):e0257421. PubMed ID: 35315711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of Porcine Reproductive and Respiratory Syndrome Virus GP5-Specific, Neutralizing Monoclonal Antibodies From Hyperimmune Sows.
    Young JE; Dvorak CMT; Graham SP; Murtaugh MP
    Front Immunol; 2021; 12():638493. PubMed ID: 33692807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.